Acute Liver Failure Due to Etodolac, a Selective Cycloxygenase- 2 (COX -2) Inhibitor Non-Steroidal Anti-Inflammatory Drug Established by RUCAM-Based Causality Assessment.
第一作者:
Sunil,Taneja
第一单位:
Postgraduate Institute of Medical Education & Research, Chandigarh, India Department of Hepatology.
作者:
医学主题词
成年人(Adult);老年人, 80以上(Aged, 80 and over);环氧化酶2抑制剂(Cyclooxygenase 2 Inhibitors);疾病恶化(Disease Progression);依托度酸(Etodolac);致命性结局(Fatal Outcome);女(雌)性(Female);肝性脑病(Hepatic Encephalopathy);人类(Humans);肝功能衰竭, 急性(Liver Failure, Acute);肝功能试验(Liver Function Tests);危险因素(Risk Factors)
DOI
10.5604/01.3001.0010.2829
PMID
28809737
发布时间
2021-09-28
- 浏览39
Annals of hepatology
818-821页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



